Which Is The Best Investment For You? High Yield Pfizer or Higher Growth Merck? | FAST Graphs
30,164
2024-05-16に共有
If you are interested in investing in a high quality large pharmaceutical company, two of your primary choices would be Pfizer (PFE) or Merck (MRK), of course, Merck being the largest. Which one of these investments would suit you better as an investor?
In this video, Chuck Carnevale, Co-founder of FAST Graphs, a.k.a. Mr. Valuation is going to answer that question – it depends on what your goals, objectives and risk tolerances are.
Time Codes:
0:00 – Introduction by Chuck Carnevale
0:48 – Pfizer (PFE)
10:10 – Merck & Co (MRK)
Introducing The FAST Graphs’ Affiliate Program! Earn money and help other investors by introducing them to the most powerful fundamental analyzer software tool available. Help others become smarter and more profitable investors.
fastgraphs.com/fast-graphs-affiliate-program-agree…
Disclaimer: FAST Graphs is a tool designed to reveal and present information related to financial data and investment metrics. It is not intended to provide specific advice or recommendations. Instead, it offers a comprehensive view of relevant data, empowering users to make informed decisions based on their own analysis. It's your first step to a more comprehensive research and due diligence process. In short, it is a tool to think with. The opinions in this video are for informational and educational purposes only and should not be construed as a recommendation to buy or sell the stocks mentioned.
Sign up for your 7-day free trial:
www.fastgraphs.com/
SUBSCRIBE To Our YouTube Channel
#investing #merck #pfizer
コメント (21)
-
An update on Bristol Myers would be great. Thanks.
-
I got in on PFE at 30 by selling puts so my cost basis is 27 and selling calls on it to lower it. I would like to see a video on BMY if possible, thank you.
-
Great presentation as always. I bought Pfizer at $25 and change so I’m already up. It seemed like a no brainer. It is still a good buy.
-
What is about Bristol-Myers Squibb? Can you maybe give us an Update? Greetings from Germany :)
-
thanks Chuck, I too would like an update on BMY as well.
-
Thumbs up. Recently started acquiring Pfizer. Not sure what makes me more excited- Pfizer having spent quite a bit on cancer related acquisitions or the potential yield on cost increases. Either way, I feel like it’s a win. If any of my dollars help cancer patients, I’m happy. If I make money I’m happy.. win/win!
-
Great stuff as always! Any thoughts on Whirlpool? I enjoyed your video years ago, "let's take it for a whirl" if memory serves...
-
Thank you very very much for this kind of content - for free!
-
Thanks Chuck!
-
Can you do Bmy analysis sir?
-
I’m buying both! 🚀🤑💎👐
-
what is the problem with BMY?
-
Hi Chuck, how come a negative growth stock should be valued at a 15 PE and a 2% positive growth valued as 13 PE? It doesn't make sense. Shouldn't the negative growth be somewhat truncated at the 13 PE?
-
With Pharma it is always difficult to convert pipeline to future (3-8 years) growth numbers for outsiders.
-
Ty boss as my experience in the pharmacy these are big names. But handful of big boys out there as well.
-
Excellent video thanks
-
thank you
-
Yes as always great information thank's from europe
-
Bought Merck at $82. I think I’ll hold for a bit longer.
-
this is a tale of two patent cliffs. Pfizer is probably the better risk reward based on price as well as the diversity of expiring portfolio vs Jupiter size Keytruda's pending exclusivity implosion
